ISR Share Price

Open 0.60 Change Price %
High 0.63 1 Day 0.03 5.00
Low 0.57 1 Week -0.03 -4.55
Close 0.63 1 Month 0.06 10.53
Volume 198256 1 Year 0.03 5.00
52 Week High 1.30
52 Week Low 0.48
ISR Important Levels
Resistance 2 0.69
Resistance 1 0.66
Pivot 0.61
Support 1 0.60
Support 2 0.57
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
RBY 0.03 -70.00%
NAK 2.46 -2.77%
NAK 2.46 -2.77%
NGD 4.16 1.22%
NGD 4.16 1.22%
PBTH 8.23 0.37%
BTI 116.76 2.29%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
GMO 0.38 22.58%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
INV 0.14 -17.65%
More..

IsoRay, Inc. (AMEX: ISR)

ISR Technical Analysis 2
As on 19th Jan 2017 ISR Share Price closed @ 0.63 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.78 & Buy for SHORT-TERM with Stoploss of 0.60 we also expect STOCK to react on Following IMPORTANT LEVELS.
ISR Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ISR Other Details
Segment EQ
Market Capital 20927304.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.isoray.com
ISR Address
ISR
350 Hills Street
Suite 106
Richland, WA 99354
United States
Phone: 509-375-1202
ISR Latest News
IsoRay's chief financial officer resigns   Puget Sound Business Journal (Seattle) (blog)   - 19th Jan 17
Bounding Shares, What's Next for IsoRay, Inc. (:ISR)   Prospect Journal   - 19th Jan 17
BRIEF-Isoray Inc's CFO Brien Ragle to resign   Reuters   - 17th Jan 17
Form 8-K IsoRay, Inc. For: Jan 16   StreetInsider.com   - 17th Jan 17
IsoRay, Inc. Announces the Launch of a Pilot Study Using Intraoperative ...   PR Newswire (press release)   - 21st Dec 16
IsoRay Announces "Cesium-131 Brachytherapy for Salvage of Recurrent High Grade ...   PR Newswire (press release)   - 29th Nov 16
IsoRay, Inc. Announces Date for Fiscal 2017 Annual Meeting and Shareholder ...   PR Newswire (press release)   - 21st Oct 16
IsoRay® Announces Results of Prospective Trial Presented at Society of Neuro ...   PR Newswire (press release)   - 21st Jun 16
IsoRay, Inc. Announces Annual Meeting and Shareholder Record Dates   PR Newswire (press release)   - 09th Apr 16
IsoRay Inc.   MarketWatch   - 22nd Dec 09
Interactive Technical Analysis Chart IsoRay, Inc. ( ISR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on IsoRay, Inc.
ISR Business Profile
IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is based in Richland, Washington.